summary
Introduced
01/23/2017
01/23/2017
In Committee
01/23/2017
01/23/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
190th General Court
Bill Summary
Relative to cost control of pharmaceutical drug prices. Public Health.
AI Summary
This bill aims to promote transparency and cost control of pharmaceutical drug prices. It requires the Health Policy Commission to develop a list of critical prescription drugs and mandate manufacturers to report detailed information about the costs of production, research and development, marketing, and pricing of these drugs. The commission is also tasked with analyzing the impact of discounts, rebates, and other forms of patient assistance programs on drug costs and utilization. The bill aims to provide more visibility into drug pricing and its impact on healthcare spending in Massachusetts.
Committee Categories
Health and Social Services
Sponsors (21)
Ruth Balser (D),
James Cantwell (D),
Mike Connolly (D),
Josh Cutler (D),
Marjorie Decker (D),
Diana Dizoglio (D),
Jamie Eldridge (D),
Carmine Gentile (D),
Paul Heroux (D),
Adam Hinds (D),
Peter Kocot (D),
Eric Lesser (D),
Jason Lewis (D),
Joan Lovely (D),
Matt Muratore (R),
Denise Provost (D),
John Scibak (D),
José Tosado (D),
Steve Ultrino (D),
Tom Walsh (D),
Timothy Whelan (R),
Last Action
Accompanied a study order, see H4625 (on 06/18/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/190/H1228 |
| Bill | https://malegislature.gov/Bills/190/H1228.pdf |
Loading...